Pacira Biosciences
PCRX
#6218
Rank
ยฃ0.64 B
Marketcap
ยฃ15.01
Share price
2.24%
Change (1 day)
-29.93%
Change (1 year)
Categories

Earnings for Pacira Biosciences (PCRX)

Earnings in 2025 (TTM): ยฃ32.75 Million

According to Pacira Biosciences 's latest financial reports the company's current earnings are ยฃ0.71 Billion. In 2024 the company made an earning of -ยฃ46.12 Million a decrease over its 2023 earnings that were of ยฃ45.08 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Pacira Biosciences from 2010 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) ยฃ32.75 M-171.04%
2024 -ยฃ46.12 Million-202.28%
2023 ยฃ45.08 M363.85%
2022 ยฃ9.72 M-76.42%
2021 ยฃ41.21 M180.76%
2020 ยฃ14.68 M-286.92%
2019 -ยฃ7.86 Million2428.94%
2018 -ยฃ0.32 Million-99%
2017 -ยฃ31.04 Million12.23%
2016 -ยฃ27.66 Million-1885.05%
2015 ยฃ1.54 M-115.65%
2014 -ยฃ9.9 Million-78.95%
2013 -ยฃ47.03 Million21.55%
2012 -ยฃ38.69 Million41.18%
2011 -ยฃ27.41 Million57.4%
2010 -ยฃ17.41 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Zogenix
ZGNX
-ยฃ0.16 Billion-606.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
ยฃ2.75 M-91.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
-ยฃ87.36 Million-385.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-ยฃ58.02 Million-289.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
-ยฃ9.93 Million-132.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-ยฃ45.89 Million-250.12%๐Ÿ‡บ๐Ÿ‡ธ USA